These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2407495)

  • 21. Clinical pharmacology of perindopril.
    Lees KR
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():7-8; discussion 9-11. PubMed ID: 2283658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term acceptability of perindopril: European multicenter trial on 856 patients.
    Degaute JP; Leeman M; Desche P
    Am J Med; 1992 Apr; 92(4B):84S-90S. PubMed ID: 1580287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Todd PA; Fitton A
    Drugs; 1991 Jul; 42(1):90-114. PubMed ID: 1718688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of perindopril in hypertension.
    Morgan T; Anderson A
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():61-5. PubMed ID: 1395118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V; Boccanelli A; Ewald S; Girerd X; Heagerty A; Krzesinski JM; Lins R; Rodicio J; Stefenelli T; Woittiez A; Böhm M
    Clin Drug Investig; 2007; 27(8):545-58. PubMed ID: 17638395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of perindopril on blood pressure in humans on different sodium intakes.
    Morgan T; Anderson A; Wilson D; Murphy J; Nowson C
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S116-8. PubMed ID: 2485043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
    Brown CL; Backhouse CI; Grippat JC; Santoni JP
    Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
    Stumpe KO; Overlack A
    Am J Cardiol; 1993 Jun; 71(17):32E-37E. PubMed ID: 8328365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
    Widimský J; Fedelesová V; Uhlír O
    Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P; Overlack A; Agnes E; Desche P
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group.
    Pauly NC; Safar ME
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S73-6. PubMed ID: 7527106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM; Santoni JP; Thomas JR; Van de Voorde K; Ketelslegers JM; Lambert AE
    Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects.
    Patel V; Rassam SM; Chen HC; Jones M; Kohner EM
    Metabolism; 1998 Dec; 47(12 Suppl 1):28-33. PubMed ID: 9867068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE
    Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
    Cheung DG; Gasster JL; Weber MA
    Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
    Asmar RG; Pannier BM; Santoni JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S79-81. PubMed ID: 3225692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM; Schaefer A
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis.
    Gasowski J; Wilkins A; Drzewoski J; Kłoś J; Gaciong Z; Kabat M; Grodzicki T
    Cardiol J; 2010; 17(3):259-66. PubMed ID: 20535716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
    Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
    Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.